Sustainability | January 24, 2026
Lupin receives highest ESG rating from CDP for climate change and water security
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
The company had achieved the highest "A" rating in Climate Change
This rating reflects Lupin's leadership in environmental transparency and performance
Fenebrutinib targets cells in the immune system known as B cells and microglia
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Phase 3 study results will form the basis for future discussions with global regulatory authorities
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
Subscribe To Our Newsletter & Stay Updated
